Sector: MedicalArray BioPharma Inc. (NASDAQ: ARRY)
Headlines
- Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2010
Nov 02, 2009 04:30 PM | ARRY
- Array BioPharma to Report Financial Results for the First Quarter of Fiscal 2010 on November 2, 2009
Oct 28, 2009 11:44 AM | ARRY
- Oncothyreon announces appointment of Douglas E. Williams, Ph.D., to board of directors
Oct 05, 2009 08:04 AM | AMGN, ARRY, ONTY, SGEN, ZGEN
- Array BioPharma to Present Clinical Results on Diabetes Drug at European Diabetes Meeting
Oct 01, 2009 06:25 PM | ARRY
- Array BioPharma Enters into Equity Distribution Agreement
Sep 18, 2009 08:00 AM | ARRY, PJC
- Array BioPharma to Present at the UBS Global Life Sciences Conference
Sep 15, 2009 10:00 AM | ARRY, UBS
- Array BioPharma Announces Top-Line Results from Rheumatoid Arthritis Phase 2 Trial
Sep 03, 2009 06:30 PM | ARRY
- Array BioPharma to Present at the Baird 2009 Healthcare Conference and the Thomas Weisel Partners 2009 Healthcare Conference
Sep 02, 2009 12:38 PM | ARRY
- Morphosys – A Biotech Rule Breaker
Mar 31, 2009 04:45 PM | ARRY, CELG, CEPH, DNA, INCY, JNJ
- Earnings Review: February 02, 2009
Feb 02, 2009 08:24 PM | AFL, APC, ARRY, HOLX, PCL, PRE
- Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2009
Aug 10, 2009 04:35 PM | ARRY
- Array BioPharma Reports Positive Results of Its Oral Glucokinase Activator in Type 2 Diabetes Patients
Aug 10, 2009 04:31 PM | ARRY
- Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2009 on August 10, 2009
Aug 05, 2009 02:03 PM | ARRY
- Array BioPharma Advances Its Lead MEK Inhibitor into Cancer
Jul 15, 2009 04:07 PM | ARRY
- Array BioPharma Announces Top-Line Results in Two Phase 1 Clinical Trials
Jul 08, 2009 04:32 PM | ARRY
- Array BioPharma to Present at the Jefferies 3rd Annual Healthcare Conference
Jun 11, 2009 03:34 PM | ARRY
- Array BioPharma Recognized by CIO Magazine as One of the CIO 100 Award Honorees
Jun 02, 2009 04:36 PM | ARRY
- Array BioPharma Receives Additional $40 Million Funding Commitment
May 19, 2009 04:04 PM | ARRY
- Array BioPharma to Present at Leerink Swann Oncology Roundtable Conference
May 12, 2009 12:52 PM | ARRY
- Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2009
May 04, 2009 04:43 PM | ARRY
- Form 4 ARRAY BIOPHARMA INC For: Oct 29 Filed by: ZABRISKIE JOHN L (10K)
Oct 30, 2009 08:08 PM
- Form 4 WILLIAMS DOUGLAS E For: Oct 29 (10K)
Oct 30, 2009 08:06 PM
- Form 4 ARRAY BIOPHARMA INC For: Oct 29 Filed by: VAN LUNSEN GIL J (10K)
Oct 30, 2009 08:04 PM
- Form 4 ARRAY BIOPHARMA INC For: Oct 29 Filed by: LEFKOFF KYLE (10K)
Oct 30, 2009 08:02 PM
- Form 4 ARRAY BIOPHARMA INC For: Oct 29 Filed by: CARUTHERS MARVIN H (10K)
Oct 30, 2009 07:59 PM
- Form 4 BULLOCK FRANCIS J For: Oct 29 (10K)
Oct 30, 2009 07:48 PM
- Form 4 ARRAY BIOPHARMA INC For: Oct 23 Filed by: CARRUTHERS MICHAEL (10K)
Oct 26, 2009 06:26 PM
- Form 4 ARRAY BIOPHARMA INC For: Oct 08 Filed by: CONWAY ROBERT (10K)
Oct 13, 2009 01:39 PM
- Form 4 ARRAY BIOPHARMA INC For: Oct 05 Filed by: SNITMAN DAVID (10K)
Oct 06, 2009 09:06 PM
- Form 4 ARRAY BIOPHARMA INC For: Oct 05 Filed by: MOORE JOHN R (10K)
Oct 06, 2009 09:05 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
ARRY
|
Compare to S&P
|
| YTD |
-55.80 %
|
-61.47 %
|
| 4 Weeks |
-25.73 %
|
-26.51 %
|
| 12 Weeks |
-55.80 %
|
-56.90 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 0.00 %
|
|
EPS Growth in Last Year: 19.12 %
|
|
Sales Growth in Last Quarter: -8.79 %
|
|
Sales Growth in Last Quarter: -9.51 %
|
|
